LipoNexus, Inc.
Developer of a non-invasive blood biomarker diagnostic test for MASLD (metabolic dysfunction-associated steatotic liver disease). The organization emphasizes lipidomics expertise and seeks clinical and commercial partnerships for test deployment, patient stratification and companion diagnostics. Headquartered in San Diego, CA.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Non-invasive blood biomarker test for MASLD
A blood-based diagnostic intended to detect or stratify metabolic dysfunction-associated steatotic liver disease without invasive procedures.
Non-invasive blood biomarker test for MASLD
A blood-based diagnostic intended to detect or stratify metabolic dysfunction-associated steatotic liver disease without invasive procedures.
Services
Collaboration opportunities with clinical and functional medicine partners for patient stratification, clinical validation, and companion diagnostic development.
Collaboration opportunities with clinical and functional medicine partners for patient stratification, clinical validation, and companion diagnostic development.
Expertise Areas
- Biomarker-based diagnostic development
- Lipidomics and metabolite pathway analysis
- Translational research in liver disease
- Clinical partnerships and patient stratification
Key Technologies
- Blood-based biomarker assays
- Lipidomics / lipid metabolite pathway analysis
- Non-invasive diagnostic testing
- Companion-diagnostic development